<DOC>
	<DOCNO>NCT01470742</DOCNO>
	<brief_summary>The objective trial compare Overall survival capecitabine plus oxaliplatin ( XELOX ) capecitabine ( X ) first-line chemotherapy elderly patient advance gastric cancer .</brief_summary>
	<brief_title>Trial Comparing Capecitabine Plus Oxaliplatin ( XELOX ) Capecitabine ( X ) First-line Chemotherapy Elderly Patients With Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>1 . Age ≥ 70 2 . Histologically cytologically confirm adenocarcinoma gastric 3 . Advanced , metastatic/recurrence gastric cancer 4 . ECOG performance status 0 2 5 . Life expectancy≥3months 6 . No history systemic anticancer chemotherapy ( prior adjuvant chemoradiation chemotherapy allow last date drug administration &gt; 6months study entry date ) 7 . No history radiation therapy Target lesion . ( Prior radiotherapy permit administered target lesion select study , unless progression select target lesion within radiation portal document , provide complete least 4 week randomization . 8 . Adequate marrow function ( ANC ≥ 1,500/uL , PLT ≥100,000/uL ) 9 . Adequate renal function ( Creatinine ≤1.5mg/dL Ccr ≥ 50ml/min ) 10 . Adequate hepatic function ( bilirubin ≤ 2.0mg/dL , SGOT/SGPT &lt; normal x 3 ) 11. provision sign write informed consent 1 . History medical psychiatric condition 2 . Active infection 3 . Peripheral neuropathy symptom ( NCICTCAE ver . 3.0 &gt; =Grade 1 ) 4. symptomatic brain metastasis 5 . Double primary cancer ( physician discretion cancer cure purpose early cancer case register ) 6 . History malignancy except : Adequately treat nonmelanomatous skin cancer cervical carcinoma situ 7 . Known hypersensitivity Fluoropyrimidines/platinum 8 . Clinical significant cardiovascular disease ( myocardial infarction , symptomatic coronary artery disease , congestive heart failure , severe arrhythmia ) 9 . Required immunosuppressive therapy ( transplant patient , severe autoimmune disease )</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>